It also contributes to pathological neovascularization and vascular remodeling in both rare hereditary conditions such as PVOD and PCH—caused by EIF2AK4 loss-of-function mutations—and in tumor-associated angiogenesis [95]. Here, EIF2AK4 is linked to pulmonary venoocclusive disease.